Cargando…

Polycystic Ovary Syndrome and Cardiovascular Diseases: Still an Open Door

Detalles Bibliográficos
Autor principal:	Malachias, Marcus Vinicius Bolivar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Cardiologia - SBC 2019
Materias:	Short Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6459439/ https://www.ncbi.nlm.nih.gov/pubmed/30994722 http://dx.doi.org/10.5935/abc.20190062

Ejemplares similares

The Challenges of Controlling Arterial Hypertension in the Elderly
por: Malachias, Marcus Vinicius Bolivar
Publicado: (2019)

Polycystic Ovary Syndrome: Familiar to Millions?
por: Ott, Johannes
Publicado: (2020)

The Open Door for Quackery
Publicado: (1892)

Polycystic Ovary Syndrome: Past, Present and Future
por: Meczekalski, Blazej
Publicado: (2023)

Molecular Research on Polycystic Ovary Syndrome (PCOS)
por: Daniele, Simona, et al.
Publicado: (2023)

Women with Polycystic Ovary Syndrome and Risk of Cardiovascular Disease
por: Blagojevic, Iva Perovic, et al.
Publicado: (2017)

Cardiovascular disease risk in offspring of polycystic ovary syndrome
por: Shawky, Noha M.
Publicado: (2022)

Biomediators in Polycystic Ovary Syndrome and Cardiovascular Risk
por: Pandurevic, Srdan, et al.
Publicado: (2021)

NT-proBNP as a predictor of death and cardiovascular events in patients with type 2 diabetes
por: Malachias, Marcus Vinicius Bolivar, et al.
Publicado: (2022)

Open Access: Is There a Predator at the Door?
por: Chandra, Rakesh, et al.
Publicado: (2018)

Polycystic Ovary Syndrome: An Apparently Simple yet Challenging Diagnosis
por: Ramezani Tehrani, Fahimeh
Publicado: (2015)

Current Management of Polycystic Ovary Syndrome: From Bench to Bedside
por: Laganà, Antonio Simone, et al.
Publicado: (2018)

Inflammatory mediators in polycystic ovary syndrome: the case of interleukin-18
Publicado: (2022)

Polycystic ovary syndrome: What more can be done for patients?
por: The Lancet Regional Health – Europe
Publicado: (2022)

Polycystic ovary syndrome: deciphering mechanisms to facilitate management and treatment
por: eBioMedicine
Publicado: (2023)

Hydroalcoholic extract of flaxseed improves polycystic ovary syndrome in a rat model
por: Jelodar, Gholamali, et al.
Publicado: (2018)

APSP will open the door to global periodontal health
por: Chung, Jae-Eun, et al.
Publicado: (2019)

Many lessons still to learn about autosomal dominant polycystic kidney disease
por: Orr, Sarah, et al.
Publicado: (2023)

Polycystic Ovary Syndrome
por: Franks, Stephen
Publicado: (1998)

Myo-inositol for insulin resistance, metabolic syndrome, polycystic ovary syndrome and gestational diabetes
por: DiNicolantonio, James J, et al.
Publicado: (2022)

Evidence-Based and Patient-Oriented Inositol Treatment in Polycystic Ovary Syndrome: Changing the Perspective of the Disease
por: Laganà, Antonio Simone, et al.
Publicado: (2017)

Association between Insulin Resistance and Cardiovascular Risk Factors in Polycystic Ovary Syndrome Patients
por: Wanderley, Miriam da Silva, et al.
Publicado: (2018)

The glucose metabolism disorder and dyslipidemia among girls with different phenotype polycystic ovary syndrome
por: Akbarzadeh, Marzieh, et al.
Publicado: (2019)

Psychological Distress in Women with Polycystic Ovary Syndrome from Imam Khomeini Hospital, Tehran
por: Zangeneh, Farideh Zafari, et al.
Publicado: (2012)

Oxidative stress and anti-oxidant defense system in Iranian women with polycystic ovary syndrome
por: Moti, Mahtab, et al.
Publicado: (2015)

From anonymity to “open doors”: IRB responses to tensions with researchers
por: Klitzman, Robert
Publicado: (2012)

Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome
por: Glintborg, Dorte, et al.
Publicado: (2018)

Impact of Increased Oxidative Stress on Cardiovascular Diseases in Women With Polycystic Ovary Syndrome
por: Duică, Florentina, et al.
Publicado: (2021)

Heart rate variability in normal-weight patients with polycystic ovary syndrome
por: Perini, Renza
Publicado: (2017)

Infective Endocarditis: Still a Deadly Disease
por: Lamas, Cristiane da Cruz
Publicado: (2020)

Cardiovascular Risk in Psoriasis Patients: Clinical, Functional and Morphological Parameters
por: de Oliveira, Angélica Navarro, et al.
Publicado: (2019)

Kisspeptin and Polycystic Ovary Syndrome
por: Tang, Rong, et al.
Publicado: (2019)

Polycystic Ovary Syndrome in Adolescence
por: Deans, Rebecca
Publicado: (2019)

Pregnancy in polycystic ovary syndrome
por: Kamalanathan, Sadishkumar, et al.
Publicado: (2013)

The inositols and polycystic ovary syndrome
por: Kalra, Bharti, et al.
Publicado: (2016)

On the Therapy for Polycystic Ovary Syndrome
por: Unfer, Vittorio, et al.
Publicado: (2017)

Update on polycystic ovary syndrome
por: Kim, Jin Ju
Publicado: (2021)

Quercetin and polycystic ovary syndrome
por: Ma, Congshun, et al.
Publicado: (2022)

Cardiovascular disease risk in women with hyperandrogenism, oligomenorrhea/menstrual irregularity or polycystic ovaries (components of polycystic ovary syndrome): a systematic review and meta-analysis
por: Lo, Andre C Q, et al.
Publicado: (2023)

Is polycystic ovary syndrome a hypothalamic disease?
por: Gaspar, Joana M.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_l9666s45q04tjsb8sdjv03cas5